A specific lot of the widely prescribed anti-anxiety drug Xanax has been recalled nationwide for not passing quality control tests according to the Food and Drug Administration.
A batch of Xanax XR is recalled due to improper dissolution, posing potential health risks. The FDA advises patients to consult their doctors for alternatives.
WASHINGTON, D.C. -- A nationwide recall has been issued for a specific lot of Xanax XR, a commonly prescribed anxiety medication, after federal regulators and the drug’s manufacturer flagged a ...
It's currently in the crosshairs for broader reasons—but here's why the FDA has announced its recall and quality risk this ...
NEW YORK (WPIX) – A widely prescribed medication for treating anxiety and panic disorders is being recalled nationwide, according to the U.S. Food and Drug Administration. A specific lot of ...
If you take the prescription drug Xanax, you might want to consult your doctor before continuing to take it. According to the U.S. Food and Drug Administration, Viatris, the manufacturer of Xanax, ...
(NEXSTAR) – The recall of a drug commonly used to treat anxiety and panic disorders may have you checking your medicine cabinet to see if you’re impacted. Thankfully, there may not be much cause for ...
A widely prescribed anxiety medication is being pulled from shelves nationwide after a quality issue triggered a recall from the U.S. Food and Drug Administration. The FDA announced that a specific ...
The FDA has designated it a class II recall.
The FDA issued a voluntary recall of Xanax XR manufactured by Viatris due to failure to meet dissolution specifications, which could make the drug less effective. Experts advise continuing your ...
One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says By HealthDay Staff HealthDay ReporterTHURSDAY, April 16, 2026 (HealthDay News) — A widely used anxiety medication is being pulled from ...
A batch of Xanax XR is being recalled nationwide after the manufacturer found it may not release the medication in the body as intended. Viatris, Inc. initiated the voluntary recall for ALPRAZolam ...